Transdermal & Intradermal Drug Delivery Systems 2017

September 28, 2017

Transdermal & Intradermal Drug Delivery Systems 2017 | Sept. 28-29 | Philadelphia

Want to Learn How to Bypass Costly Clinical Trials for Your Topical Products? Ask Us How In Philly!

A recent guidance from the FDA will allow acyclovir cream products to bypass human clinical trials, replacing them with a method using in vitro release testing (IVRT) and in vitro permeation testing (IVPT). Let Diteba, a Nutrasource company, show you how you may be able to save substantial time and money in your development program. 

Don’t Miss:

Theo Kapanadze, D.Sc., Ph.D., co-founder and chief scientific officer of Diteba, will also be presenting on “The Advances in Bioequivalence Assessment of Generic Topical Drugs,” at 8:00 a.m. on Friday, Sept. 29. 

Interested in the topic and want to be prepared?

Download our white paper now

Schedule a meeting with us

Back to News